Cost-effective therapy for hypertension

Area of Science:

• Cardiology
• Pharmacology
• General Medicine

Background:

• Rising costs associated with hypertension management.
• Current guidelines recommend diuretics and beta-blockers as first-line therapy.
• Emergence of newer antihypertensive agents with improved metabolic profiles but unproven long-term outcomes.

Purpose of the Study:

• To review current drug utilization for hypertension in a general medicine clinic.
• To evaluate the existing literature on newer antihypertensive agents.
• To develop clinical guidelines for cost-effective and proven hypertension therapy.

Main Methods:

• Review of drug prescription patterns within the General Medicine Clinic.
• Comprehensive literature evaluation of randomized controlled trials for hypertension medications.
• Development of clinical guidelines based on evidence and clinician feedback.

Main Results:

• The clinic's prescribing patterns have shifted towards newer hypertension agents.
• Clinician concerns regarding quality of life, sexual dysfunction, and metabolic changes (lipids, potassium, insulin resistance) were identified.
• Evidence regarding the long-term efficacy and safety of newer agents in reducing morbidity and mortality remains limited.

Conclusions:

• A consensus was reached to address clinician concerns and guide medication choices.
• Recommendations focus on streamlining therapy and reducing healthcare costs.
• The goal is to ensure the provision of proven effective hypertension medications.